PharVision Advisers’s ICICI Bank IBN Stock Holding History

PharVision Advisers’s Portfolio IBN Stock Details IBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,246	Closed	-$276K	–	357
2025 Q4	$276K	Buy	+9,246	New	+$284K	0.14%	327

Other funds holding IBN

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

PharVision Advisers's IBN Position: Q1 2026 in Review

PharVision Advisers sold out of ICICI Bank (IBN) in Q1 2026, closing a stake of 9,246 shares — an estimated $276K sold.

PharVision Advisers first reported a position in IBN in Q4 2025 and held it in 1 quarter. The position peaked at $276K in Q4 2025. 547 funds tracked by Wall St. Rank hold IBN as of Q1 2026.

PharVision Advisers reported no remaining ICICI Bank position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 9,246 ICICI Bank shares in Q1 2026, an estimated $276K.
PharVision Advisers first reported a position in ICICI Bank in Q4 2025 and held it in 1 quarter.
PharVision Advisers's ICICI Bank position peaked at $276K in Q4 2025.
547 funds tracked by Wall St. Rank held ICICI Bank as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.